Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized
Céline Bourgier1, Jérôme Lacombe2, Jérôme Solassol3
1University of Montpellier I, Montpellier, France; Institut de Recherche en Cancérologie de Montpellier, Montpellier, France; Institut régional du Cancer de Montpellier (ICM) - Val d'Aurelle, Department of Radiotherapy, Montpellier, France.
Abstract:
Radiation therapy undeniably enhances local control and thus improves overall survival in cancer patients. However, some long-term cancer survivors (less than 10%) develop severe late radio-induced toxicities altering their quality of life. Therefore, there is a need to identify patients who are sensitive to those toxicities and who could benefit from adapted care. In this review, we address all available techniques aiming to detect patients' hyper-radiosensitivity and present the scientific rationales these techniques are based on.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Targeted Cancer Therapies
There are several types of targeted therapies against...

